Angiography Equipment Market

Growing technological development is driving the market growth

Market CAGR for angiography equipment is driven by the increased demand for new imaging technologies like magnetic resonance imaging (MRI), computed tomography (CT), and flat-panel detectors is expected to boost the worldwide angiography equipment market in the coming years. The angiography equipment market is projected to expand during the next few years due to some factors, including the rising incidence of cardiovascular diseases, the aging of the population, and the preference for more advanced angiography techniques. Increasing interest in using interventional angiography equipment in keyhole procedures.

People are increasingly choosing these procedures since they are less expensive and risky than standard surgical procedures.

Additionally, the rise in the elderly population, the prevalence of coronary artery disease, and the prevalence of cardiovascular disease worldwide. Demand for interventional angiography systems in minimally invasive operations is a major driver of the market's expansion and rising awareness programs, conferences, and financing activities. Minimally invasive operations are becoming increasingly popular, and supportive government initiatives and reimbursement policies in developed economies are expected to fuel the market's expansion. Therefore, the increasing prevalence of these diseases is fueling the expansion of the international market.

For instance, AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System for the treatment of acute intermediate-risk pulmonary embolism (PE) AngioDynamics has announced the launch of the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV), a new clinical study to determine the device's reliability and safety. As a result, the demand for angiography equipment is predicted to grow throughout the forecasted time due to rising technological advancement. Thus, the driving factor is the angiography equipment market revenue.

The Global Angiography Equipment Market Industry is projected to experience substantial growth over the next decade. With a market value expected to reach 9.41 USD Billion in 2024 and 16.4 USD Billion by 2035, the industry is poised for a robust expansion. The compound annual growth rate of 5.2% from 2025 to 2035 suggests a steady increase in demand for angiography systems. This growth is likely driven by technological advancements, rising healthcare expenditures, and an increasing prevalence of cardiovascular diseases. As the market evolves, it will be essential for stakeholders to adapt to changing trends and invest in innovative solutions to meet the growing needs of healthcare providers and patients.

The Global Angiography Equipment Market Industry is experiencing rapid technological advancements, which are enhancing the efficacy and precision of diagnostic procedures. Innovations such as 3D imaging, real-time visualization, and advanced catheter designs are becoming increasingly prevalent. These developments not only improve patient outcomes but also streamline workflows in healthcare facilities. As a result, the market is projected to reach 9.41 USD Billion in 2024, driven by the demand for more sophisticated imaging solutions. The integration of artificial intelligence and machine learning into angiography systems further indicates a shift towards more automated and accurate diagnostic tools, potentially revolutionizing the industry.

The Global Angiography Equipment Market Industry is benefiting from increasing healthcare expenditure across various regions. Governments and private sectors are investing more in healthcare infrastructure, which includes the procurement of advanced medical equipment. This trend is particularly evident in emerging economies, where improved access to healthcare services is driving demand for angiography systems. The projected compound annual growth rate of 5.2% from 2025 to 2035 indicates a robust market trajectory, fueled by these investments. Enhanced funding for healthcare initiatives is likely to facilitate the adoption of cutting-edge angiography technologies, thereby improving diagnostic capabilities and patient care.

The Global Angiography Equipment Market Industry is significantly influenced by the rising prevalence of cardiovascular diseases, which are among the leading causes of mortality worldwide. As the global population ages, the incidence of conditions such as coronary artery disease and peripheral artery disease is expected to increase. This trend necessitates the use of angiography equipment for accurate diagnosis and treatment planning. The market's growth is further supported by healthcare initiatives aimed at improving cardiovascular health, leading to an anticipated market value of 16.4 USD Billion by 2035. Consequently, the demand for advanced angiography systems is likely to surge, reflecting the urgent need for effective diagnostic tools.

The Global Angiography Equipment Market Industry is positively impacted by supportive regulatory frameworks and reimbursement policies that facilitate the adoption of advanced medical technologies. Governments and health organizations are increasingly recognizing the importance of angiography in diagnosing and treating cardiovascular diseases, leading to favorable reimbursement rates for these procedures. This support encourages healthcare providers to invest in state-of-the-art angiography equipment, thereby driving market growth. As reimbursement policies evolve to cover more advanced technologies, the market is likely to see increased adoption rates, further enhancing the accessibility and affordability of angiography services for patients.

The Global Angiography Equipment Market Industry is witnessing a growing demand for minimally invasive procedures, which are preferred by both patients and healthcare providers. These procedures typically result in shorter recovery times, reduced hospital stays, and lower overall costs. Angiography plays a crucial role in facilitating such interventions, as it allows for precise imaging and guidance during procedures. The increasing awareness of the benefits of minimally invasive techniques is likely to drive the adoption of advanced angiography systems. As a result, the market is expected to expand significantly, aligning with the broader trend towards patient-centered care and improved surgical outcomes.

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American angiography equipment market will dominate because there are now so many labs and research centers in the area. In addition, its benefits from a well-established healthcare infrastructure and the expanding presence of significant important players, both of which are expected to fuel the market's expansion in this region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2  ANGIOGRAPHY EQUIPMENT MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe’s angiography equipment market accounts for the second-largest market because of the prevalence of cardiovascular disease and the existence of numerous producers, both domestic and foreign. Further, the German angiography equipment market held the largest market share, and the UK angiography equipment market was the fastest-growing market in the European area.

The Asia-Pacific angiography equipment market is expected to grow at the fastest CAGR from 2023 to 2032 due to increased angiography screening procedures, expanding adoption of angiography devices, and increased funding for cardiovascular disease research and treatment are all factors. Moreover, China’s angiography equipment market held the largest market share, and the Indian angiography equipment market was the fastest-growing market in the Asia-Pacific region.

Leading market players are investing heavily in research and development to expand their product lines, which will help the angiography equipment market grow even more. There are some strategies for action that market participants are implementing to increase their presence around the world's  footprint, with important market developments including new product launches, contractual agreements and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the angiography equipment industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics manufacturer use in the  angiography equipment industry to benefit clients and increase the market sector. In recent years, the angiography equipment industry has offered some of the most significant technological advancements. Major players in the angiography equipment market, including GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Corporation (Japan), Boston Scientific Corporation (U.S.), Cordis (a Cardinal Health Company( U.S.), Shimadzu Corporation (Japan), Medtronic (Ireland), Angiodynamics (U.S.), B.

Braun Melsungen (Germany), Abbott Laboratories (U.S.), Terumo (Japan), and others are attempting to increase market demand by investing in research and development operations.

At GE HealthCare, we think that innovation creates new opportunities. We are collaborating with our customers to reach the full potential of healthcare through cutting-edge medical technology, intelligent devices, and care solutions. Greater patient care is made possible by greater technology. Together, we are implementing universal healthcare and building a better future. Our business is run by a group of leaders who are certain that GE HealthCare enhances the lives of all of our stakeholders. They start by describing our vision for the direction of healthcare.

Together, we are digitizing healthcare, increasing productivity to improve patient lives, and creating major efficiencies for international providers and health systems. In April 2023, GE HealthCare declared that the bkActiv of the newest generation is now accessible for directing urology, colorectal, and pelvic floor surgical procedures. One of GE HealthCare's subsidiaries, BK Medical, developed the industry-leading intraoperative ultrasound imaging system with the goal of providing surgeons with high-performance ultrasound guidance that is simple and intuitive to use.

At Varian, a Siemens Healthineers company, we hope to eradicate cancer-related anxiety. For more than 75 years, Varian has created, constructed, and supplied cutting-edge technology and solutions that support the treatment of millions of patients annually by healthcare professionals all over the world. As a Siemens Healthineers company, we now support every stage of the cancer care process, from screening to survivorship. We are using the strength of our perspective while simultaneously pursuing clinical research to build a more effective and individualized care pathway. This includes advanced imaging and radiation therapy, extensive software and services, and interventional radiology.

In May 2023, an initial patient was successfully treated using Siemens Healthineers' RADIATE-VT1 clinical trial (NCT 05765175) at Washington University School of Medicine in St. Louis, Missouri. The RADIATE-VT trial is the first international, multi-center, and safety of cardiac radio ablation (CRA) versus catheter ablation for patients with high-risk, refractory (VT). The Varian CRA system will handle the planning and delivery of the cardiac radio ablation treatments.